Accelerium Clinical Research

Slow to negative growth in select emerging markets

Tuesday, March 1, 2016

A few years ago, Latin America and India were considered among the most promising emerging markets for conducting industry-sponsored clinical trials. Dramatic increases were predicted for both regions, and investigative sites anticipated an influx of new work. Unfortunately, growth in these markets has fallen far short of expectations.

[Read More]